Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · August 19, 2024

Real-World Effectiveness and Safety of Guselkumab in Patients With Moderate to Severe Plaque Psoriasis

Journal of Drugs in Dermatology

 

Additional Info

Journal of Drugs in Dermatology
Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study
J Drugs Dermatol 2024 Aug 01;23(8)632-639, L Gargiulo, L Ibba, A Cortese, F Toso, CA Vignoli, G Fiorillo, F Piscazzi, M Valenti, A Costanzo, A Narcisi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading